Cargando…

Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy

Background: Robust data summarizing the prevalence of pregnancy and neonatal outcomes in low- and middle-income countries are critically important for studies evaluating investigational products for HIV prevention and treatment in pregnant and breastfeeding women. In preparation for studies evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokken, Erica M., Mathur, Anya, Bunge, Katherine E., Fairlie, Lee, Makanani, Bonus, Beigi, Richard, Noguchi, Lisa, Balkus, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856667/
https://www.ncbi.nlm.nih.gov/pubmed/35187529
http://dx.doi.org/10.3389/frph.2021.672446
_version_ 1784653894731694080
author Lokken, Erica M.
Mathur, Anya
Bunge, Katherine E.
Fairlie, Lee
Makanani, Bonus
Beigi, Richard
Noguchi, Lisa
Balkus, Jennifer E.
author_facet Lokken, Erica M.
Mathur, Anya
Bunge, Katherine E.
Fairlie, Lee
Makanani, Bonus
Beigi, Richard
Noguchi, Lisa
Balkus, Jennifer E.
author_sort Lokken, Erica M.
collection PubMed
description Background: Robust data summarizing the prevalence of pregnancy and neonatal outcomes in low- and middle-income countries are critically important for studies evaluating investigational products for HIV prevention and treatment in pregnant and breastfeeding women. In preparation for studies evaluating the safety of the dapivirine vaginal ring for HIV prevention in pregnancy, we conducted a systematic literature review and meta-analyses to summarize the prevalence of pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe. Methods: Ten individual systematic literature reviews were conducted to identify manuscripts presenting prevalence data for 12 pregnancy and neonatal outcomes [pregnancy loss, stillbirth, preterm birth, low birthweight (LBW), neonatal mortality, congenital anomaly, chorioamnionitis, postpartum endometritis, postpartum hemorrhage, gestational hypertension, preeclampsia/eclampsia, and preterm premature rupture of membranes (PPROM)]. Studies included in the meta-analyses were published between January 1, 1998, and July 11, 2018, provided numerator and denominator data to support prevalence estimation, and included women of any HIV serostatus. Random-effects meta-analyses were conducted to estimate the pooled prevalence and 95% confidence interval (CI) for each outcome overall, by country, and by HIV status. Results: A total of 152 manuscripts were included across the 12 outcomes. Overall, the frequency of stillbirth (n = 75 estimates), LBW (n = 68), and preterm birth (n = 67) were the most often reported. However, fewer than 10 total manuscripts reported prevalence estimates for chorioamnionitis, endometritis, or PPROM. The outcomes with the highest pooled prevalence were preterm birth (12.7%, 95%CI 11.2–14.3), LBW (11.7%, 95%CI 10.6–12.9), and gestational hypertension (11.4%, 95%CI 7.8–15.7). Among the outcomes with the lowest pooled prevalence estimates were neonatal mortality (1.7%, 95%CI 1.4–2.1), pregnancy loss [1.9%, 95%CI 1.1–2.8, predominately studies (23/29) assessing losses occurring after the first trimester], PPROM (2.2%, 95%CI 1.5–3.2), and stillbirth (2.5%, 95%CI 2.2–2.7). Conclusions: Although this review identified numerous prevalence estimates for some outcomes, data were lacking for other important pregnancy-related conditions. Additional research in pregnant populations is needed for a thorough evaluation of investigational products, including for HIV prevention and treatment, and to inform better estimates of the burden of adverse pregnancy outcomes globally.
format Online
Article
Text
id pubmed-8856667
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88566672022-02-18 Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy Lokken, Erica M. Mathur, Anya Bunge, Katherine E. Fairlie, Lee Makanani, Bonus Beigi, Richard Noguchi, Lisa Balkus, Jennifer E. Front Reprod Health Reproductive Health Background: Robust data summarizing the prevalence of pregnancy and neonatal outcomes in low- and middle-income countries are critically important for studies evaluating investigational products for HIV prevention and treatment in pregnant and breastfeeding women. In preparation for studies evaluating the safety of the dapivirine vaginal ring for HIV prevention in pregnancy, we conducted a systematic literature review and meta-analyses to summarize the prevalence of pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe. Methods: Ten individual systematic literature reviews were conducted to identify manuscripts presenting prevalence data for 12 pregnancy and neonatal outcomes [pregnancy loss, stillbirth, preterm birth, low birthweight (LBW), neonatal mortality, congenital anomaly, chorioamnionitis, postpartum endometritis, postpartum hemorrhage, gestational hypertension, preeclampsia/eclampsia, and preterm premature rupture of membranes (PPROM)]. Studies included in the meta-analyses were published between January 1, 1998, and July 11, 2018, provided numerator and denominator data to support prevalence estimation, and included women of any HIV serostatus. Random-effects meta-analyses were conducted to estimate the pooled prevalence and 95% confidence interval (CI) for each outcome overall, by country, and by HIV status. Results: A total of 152 manuscripts were included across the 12 outcomes. Overall, the frequency of stillbirth (n = 75 estimates), LBW (n = 68), and preterm birth (n = 67) were the most often reported. However, fewer than 10 total manuscripts reported prevalence estimates for chorioamnionitis, endometritis, or PPROM. The outcomes with the highest pooled prevalence were preterm birth (12.7%, 95%CI 11.2–14.3), LBW (11.7%, 95%CI 10.6–12.9), and gestational hypertension (11.4%, 95%CI 7.8–15.7). Among the outcomes with the lowest pooled prevalence estimates were neonatal mortality (1.7%, 95%CI 1.4–2.1), pregnancy loss [1.9%, 95%CI 1.1–2.8, predominately studies (23/29) assessing losses occurring after the first trimester], PPROM (2.2%, 95%CI 1.5–3.2), and stillbirth (2.5%, 95%CI 2.2–2.7). Conclusions: Although this review identified numerous prevalence estimates for some outcomes, data were lacking for other important pregnancy-related conditions. Additional research in pregnant populations is needed for a thorough evaluation of investigational products, including for HIV prevention and treatment, and to inform better estimates of the burden of adverse pregnancy outcomes globally. Frontiers Media S.A. 2021-11-26 /pmc/articles/PMC8856667/ /pubmed/35187529 http://dx.doi.org/10.3389/frph.2021.672446 Text en Copyright © 2021 Lokken, Mathur, Bunge, Fairlie, Makanani, Beigi, Noguchi and Balkus. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Reproductive Health
Lokken, Erica M.
Mathur, Anya
Bunge, Katherine E.
Fairlie, Lee
Makanani, Bonus
Beigi, Richard
Noguchi, Lisa
Balkus, Jennifer E.
Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
title Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
title_full Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
title_fullStr Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
title_full_unstemmed Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
title_short Pooled Prevalence of Adverse Pregnancy and Neonatal Outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results From a Systematic Review and Meta-Analyses to Inform Trials of Novel HIV Prevention Interventions During Pregnancy
title_sort pooled prevalence of adverse pregnancy and neonatal outcomes in malawi, south africa, uganda, and zimbabwe: results from a systematic review and meta-analyses to inform trials of novel hiv prevention interventions during pregnancy
topic Reproductive Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856667/
https://www.ncbi.nlm.nih.gov/pubmed/35187529
http://dx.doi.org/10.3389/frph.2021.672446
work_keys_str_mv AT lokkenericam pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT mathuranya pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT bungekatherinee pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT fairlielee pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT makananibonus pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT beigirichard pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT noguchilisa pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy
AT balkusjennifere pooledprevalenceofadversepregnancyandneonataloutcomesinmalawisouthafricaugandaandzimbabweresultsfromasystematicreviewandmetaanalysestoinformtrialsofnovelhivpreventioninterventionsduringpregnancy